Immunisation update

Nirsevimab ordering available for the 2025 RSV Prevention Program

Nirsevimab (brand name BeyfortusTM), an RSV long-acting monoclonal antibody, is available to order from the NSW Vaccine Centre for the 2025 NSW RSV Prevention Program.

To order nirsevimab, use the new nirsevimab vaccine order form. The form has been updated to enable up to 5 children to be added to the same order form. Please complete the patient details for each child indicating their eligibility to receive nirsevimab. Please ensure the order form is completed ahead of the patient’s appointment. Routine delivery timeframes apply.

Find out more at health.nsw.gov.au/immunisation/Pages/respiratory-syncytial-virus

Update to 2025 National Immunisation Program influenza vaccines

Sanofi’s VaxiGrip Tetra® vaccine for the 2025 influenza season is expected to arrive in early April. To ensure early access to flu vaccines for all eligible groups, a supply of Sanofi’s FluQuadri® has been made available for immunisation providers to vaccinate National Immunisation Program (NIP) eligible children aged 6 months to less than 5 years until VaxiGrip Tetra® stock is distributed.

Due to the late addition of the FluQuadri® to the program, its packaging will not be labelled with “Government Funded Program – 2025” like other NIP influenza vaccines. Immunisation providers are advised to carefully identify this stock and ensure it is only used and recorded as a NIP funded vaccination for children 6 months to less than 5 years.

Providers with questions about vaccine orders should contact their respective state or territory health departments.

For the latest 2025 NIP influenza vaccination program updates, health professionals can visit health.gov.au/flu.

A news item will be posted when the ATAGI Statement on the administration of seasonal influenza vaccines in 2025 has been updated to include this change.

Updated resources

2025 influenza vaccination – Program advice for health professionals - updated

NSW state funded immunisation schedule update - MMR eligibility

The Additional Commonwealth and NSW-funded free vaccines webpage has been updated to include MMR vaccine for infants 6 months to <12 months travelling overseas to countries where measles is endemic. 

The vaccine is been available to order for this cohort on the NSW Vaccine Centre online ordering webpage.